AlphaQuest LLC Raises Stock Position in Simulations Plus, Inc. (NASDAQ:SLP)

AlphaQuest LLC boosted its holdings in Simulations Plus, Inc. (NASDAQ:SLP) by 502.9% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 2,689 shares of the technology company’s stock after purchasing an additional 2,243 shares during the quarter. AlphaQuest LLC’s holdings in Simulations Plus were worth $75,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of the business. Proficio Capital Partners LLC purchased a new stake in Simulations Plus in the 4th quarter worth $719,000. Charles Schwab Investment Management Inc. increased its stake in Simulations Plus by 4.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 143,253 shares of the technology company’s stock worth $3,995,000 after buying an additional 6,418 shares in the last quarter. Jones Financial Companies Lllp increased its stake in Simulations Plus by 53.6% in the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock worth $34,000 after buying an additional 427 shares in the last quarter. US Bancorp DE increased its stake in Simulations Plus by 14.3% in the 4th quarter. US Bancorp DE now owns 5,687 shares of the technology company’s stock worth $159,000 after buying an additional 713 shares in the last quarter. Finally, Illumine Investment Management LLC purchased a new position in shares of Simulations Plus during the fourth quarter valued at about $280,000. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Simulations Plus Trading Up 0.6 %

Shares of NASDAQ:SLP opened at $25.51 on Thursday. Simulations Plus, Inc. has a 12 month low of $24.00 and a 12 month high of $51.22. The company has a 50-day moving average price of $31.42 and a 200 day moving average price of $31.03. The company has a market cap of $512.55 million, a price-to-earnings ratio of 63.78 and a beta of 0.89.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on SLP. KeyCorp raised their price objective on Simulations Plus from $35.00 to $37.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. William Blair restated an “outperform” rating on shares of Simulations Plus in a research report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $49.40.

Insider Activity at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $33.91, for a total value of $678,200.00. Following the completion of the transaction, the director now owns 3,402,584 shares of the company’s stock, valued at approximately $115,381,623.44. This trade represents a 0.58 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 19.40% of the stock is owned by insiders.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.